Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Premier Biosoft Partner on Lipidomics Technologies

NEW YORK (GenomeWeb News) – Agilent Technologies and Premier Biosoft today said they will support the combination of each other's technologies to advance lipidomics research.

Agilent's time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software used in conjunction with Premier's SimLipid 3.3 identification and quantification software will allow scientists to overcome obstacles that have stood in the way of lipid identification and analysis, the firms said.

"Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism," Daniel Kassel, Agilent’s senior director of LC/MS global marketing, said in a statement. "By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in Premier Biosoft’s SimLipid software."
 
Premier CEO Arun Apte added, "Our SimLipid software supports data from Agilent’s well-known MassHunter, Mass Profiler Professional and Pathway Architect software programs, creating an integrated workflow for the accurate and efficient identification and contextualization of lipids on metabolic pathways."

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.